Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset <i>Escherichia coli</i>, <i>Klebsiella</i> Species, and <i>Proteus mirabilis</i> Bacteremia: MIC Matters
Background: Cefazolin is in vitro active against wild isolates of <i>Escherichia coli</i>, <i>Klebsiella</i> species, and <i>Proteus mirabilis</i> (EKP), but clinical evidence supporting the contemporary susceptibility breakpoint issued by the Clinical and Laborat...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/1/157 |